-
Reckitt Benckiser posts Q2 results
SLOUGH, England — Second-quarter net revenue increased to 2.34 billion pounds ($3.83 billion) for Reckitt Benckiser, the company announced in an earnings statement Monday.
The company attributed its increases to growth in developing markets. For the quarter, RB said net revenue increased by 13% and 5% on a like-for-like basis. LFL growth excludes the impact of changes in exchange rates, major acquisitions and disposals, RB noted.
-
Taro sees sales, profits spike in Q2
HAWTHORNE, N.Y. — Israeli generic drug maker Taro Pharmaceutical Industries got a big boost in sales and profits during second quarter 2011, according to a financial report released Tuesday.
Taro reported sales of $111.6 million, a 14.2% increase, compared with second quarter 2010. In addition, profits were $35.7 million, a $19.3 million increase over the same period last year.